At the recent annual International APS PharmSci conference organised by the Academy of Pharmaceutical Sciences, Professor Ijeoma Uchegbu was awarded the Innovative Science Award, sponsored by GSK for her work on translating science into practice.
The award is given to a scientist who most demonstrates the translation of scientific concepts into practical products and services (https://www.ukpharmsci.org/awards/emergingscientist.asp). The award was takes the form of a commemorative plaque and a cheque for £1000. The award recipient is also required to give a plenary lecture at the International PharmSci conference. Professor Uchegbu won the award for her translational activities, including work in her UCL spin out company, Nanomerics Ltd (www.nanomerics.com). In the plenary lecture given by Professor Uchegbu at the conference, she highlighted how the company was underpinned by its patent protected Molecular Envelope Technology, exclusively licenced from UCL, and showcased products being developed by the company, one of which was NM0147 an oral form of amphotericin B effective in the treatment of visceral leishmaniasis in animal models. Currently amphotericin B is only available as an intravenous drip, which makes it inaccessible to many patients in India, Bangladesh, Ethiopia and Sudan, where the disease is endemic. The award’s citation, given by Dr David Wyatt of GSK, recognised Professor Uchegbu’s work in establishing new nanotechnology concepts, harnessing this science for the creation of differentiated products and thus effectively demonstrating the translation of “science into practice.”